These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 22183981)

  • 1. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
    Bennett EP; Mandel U; Clausen H; Gerken TA; Fritz TA; Tabak LA
    Glycobiology; 2012 Jun; 22(6):736-56. PubMed ID: 22183981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.
    Daniel EJP; Las Rivas M; Lira-Navarrete E; García-García A; Hurtado-Guerrero R; Clausen H; Gerken TA
    Glycobiology; 2020 Oct; 30(11):910-922. PubMed ID: 32304323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, expression and properties of porcine trachea UDP-galnac: polypeptide N-acetylgalactosaminyl transferase.
    Sangadala S; Swain JB; McNear A; Mendicino J
    Mol Cell Biochem; 2004 Nov; 266(1-2):117-26. PubMed ID: 15646032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
    Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
    Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin core O-glycosylation is modulated by neighboring residue glycosylation status. Kinetic modeling of the site-specific glycosylation of the apo-porcine submaxillary mucin tandem repeat by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases T1 and T2.
    Gerken TA; Zhang J; Levine J; Elhammer A
    J Biol Chem; 2002 Dec; 277(51):49850-62. PubMed ID: 12397077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypeptide
    Kato K; Hansen L; Clausen H
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.
    Ballard CJ; Paserba MR; Paul Daniel EJ; Hurtado-Guerrero R; Gerken TA
    Glycobiology; 2023 Oct; 33(10):817-836. PubMed ID: 37555669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
    Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
    BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
    Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
    Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.
    Kong Y; Joshi HJ; Schjoldager KT; Madsen TD; Gerken TA; Vester-Christensen MB; Wandall HH; Bennett EP; Levery SB; Vakhrushev SY; Clausen H
    Glycobiology; 2015 Jan; 25(1):55-65. PubMed ID: 25155433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.
    Gerken TA; Revoredo L; Thome JJ; Tabak LA; Vester-Christensen MB; Clausen H; Gahlay GK; Jarvis DL; Johnson RW; Moniz HA; Moremen K
    J Biol Chem; 2013 Jul; 288(27):19900-14. PubMed ID: 23689369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.
    Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D
    J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree.
    Raman J; Guan Y; Perrine CL; Gerken TA; Tabak LA
    Glycobiology; 2012 Jun; 22(6):768-77. PubMed ID: 22186971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of peptide sequence and neighboring residue glycosylation on the substrate specificity of the uridine 5'-diphosphate-alpha-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl transferases T1 and T2: kinetic modeling of the porcine and canine submaxillary gland mucin tandem repeats.
    Gerken TA; Tep C; Rarick J
    Biochemistry; 2004 Aug; 43(30):9888-900. PubMed ID: 15274643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
    Wandall HH; Irazoqui F; Tarp MA; Bennett EP; Mandel U; Takeuchi H; Kato K; Irimura T; Suryanarayanan G; Hollingsworth MA; Clausen H
    Glycobiology; 2007 Apr; 17(4):374-87. PubMed ID: 17215257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane.
    Lackman JJ; Goth CK; Halim A; Vakhrushev SY; Clausen H; Petäjä-Repo UE
    Cell Signal; 2018 Jan; 42():184-193. PubMed ID: 29097258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-glycosylation in Toxoplasma gondii: identification and analysis of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.
    Stwora-Wojczyk MM; Kissinger JC; Spitalnik SL; Wojczyk BS
    Int J Parasitol; 2004 Mar; 34(3):309-22. PubMed ID: 15003492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin-type O-glycosylation and its potential use in drug and vaccine development.
    Tarp MA; Clausen H
    Biochim Biophys Acta; 2008 Mar; 1780(3):546-63. PubMed ID: 17988798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family.
    Schjoldager KT; Clausen H
    Biochim Biophys Acta; 2012 Dec; 1820(12):2079-94. PubMed ID: 23022508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation.
    Clausen H; Bennett EP
    Glycobiology; 1996 Sep; 6(6):635-46. PubMed ID: 8922959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 45.